Project 1: Brain steroid receptor coactivators and energy homeostasis
项目1:脑类固醇受体共激活剂和能量稳态
基本信息
- 批准号:10153760
- 负责人:
- 金额:$ 31.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-07-01 至 2023-04-30
- 项目状态:已结题
- 来源:
- 关键词:AblationAdipose tissueAge of OnsetAnimal ModelAnorexiaAttenuatedBiochemicalBody WeightBody mass indexBrainBrain regionCRISPR/Cas technologyCharacteristicsChildChronicClustered Regularly Interspaced Short Palindromic RepeatsCodeComplexCuesCultured CellsDNA Sequence AlterationDevelopmentDietDissociationEatingEnergy IntakeEnergy MetabolismEnsureEquilibriumEstrogen Receptor alphaFOXO1A geneFastingFatty acid glycerol estersFeeding behaviorsGenesGenetic TranscriptionGlucoseHigh Fat DietHomeostasisHourHumanHyperphagiaHypothalamic structureImpairmentIndividualInsulinKnock-in MouseLeptinLiverLocomotionMediatingMediator of activation proteinMetabolicMetabolismModelingMolecularMusMutant Strains MiceMutationNeuronsNuclear ReceptorsNutritionalObesityPPAR gammaPathway interactionsPeripheralPhasePropertyProteinsRegimenReservationsRoleSignal TransductionSignaling MoleculeStat3 proteinSteroid ReceptorsSystemTechnologyTestingThyroid Hormone ReceptorTimeTissuesUniversitiesWeight Gaincohortdiet-induced obesityenergy balanceexhibitionsfeedinginsulin sensitivitymetabolic phenotypemind controlmouse modelmutantnew therapeutic targetnovelnovel therapeuticsnuclear receptor coactivator 1obesity preventionobesity treatmentoverexpressionpreventprogramsresponsesevere early onset obesitytranscription factortranscriptome
项目摘要
Project 1 - Project Summary
Numerous nuclear receptors (NRs) or transcription factors (TFs) have been identified as important regulators of
body weight. However, anti-obesity regimens targeting these individual molecules alone are far from satisfying.
Coactivators interact with a broad range of NRs/TFs and may serve as master regulators that coordinate and
synergize actions of multiple metabolic signals. High levels of Steroid Receptor Coactivator-1 and -2 (SRC-1 and
SRC-2) are expressed in the hypothalamus, the key brain region controlling feeding and body weight balance.
The pilot observations led to a hypothesis that hypothalamic SRC-1 and SRC-2 coactivate STAT3 and FoxO1,
repectively, to provide coordinated control of energy metabolism. Aim 1 will determine whether hypothalamic
SRC-1 fine-tunes STAT3 transcription activity to mediate the anti-obesity effects of leptin. Mouse models lacking
or overexpressing SRC-1 only in leptin-responsive neurons have been generated. Metabolic parameters in
response to different diets or to leptin treatment will be assessed in these mice. Importantly, the molecular
mechanisms by which the SRC1-pSTAT3 complex regulates leptin signaling will be delineated. Aim 2 will
determine whether human SRC-1 mutations impair leptin-STAT3 pathway in the hypothalamus and cause
obesity. Using the CRISPR technology, a knockin mouse line has been generated to mimic a SRC-1 genetic
mutation associated with human obesity. Metabolic phenotypes of these mice will be characterized, and leptin-
STAT3 actions and STAT3 transcription activity will be evaluated. Aim 3 will determine whether hypothalamic
SRC-2 coativates FoxO1 transcriptional activity to facilitate energy reservations. Mice lacking or overexpressing
SRC-2 in mature POMC neurons have been generated, with/without FoxO1 overexpression. Metabolic
phenotypes will be characterized in all these models and FoxO1 transcriptional activity will also be evaluated.
项目1-项目摘要
许多核接收器(NRS)或转录因子(TF)已被确定为重要的调节剂
体重。但是,仅针对这些单个分子的抗肥胖方案远非满意。
共激活因子与广泛的NRS/TFS相互作用,并且可以用作协调和
协同多个代谢信号的动作。高水平的类固醇受体共激活剂1和2(SRC-1和-2
SRC-2)在下丘脑(控制进食和体重平衡的关键大脑区域)中表达。
试点观察结果导致了下丘脑SRC-1和SRC-2共激活STAT3和FOXO1的假设,
分别提供对能量代谢的协调控制。 AIM 1将确定下丘脑是否
SRC-1微型STAT3转录活性以介导瘦素的抗肥胖作用。鼠标模型缺乏
或仅在瘦素反应性神经元中过度表达SRC-1。代谢参数中
在这些小鼠中将评估对不同饮食或瘦素治疗的反应。重要的是,分子
SRC1-PSTAT3复合物调节瘦素信号传导的机制将被描述。 AIM 2意志
确定人类SRC-1突变是否会损害下丘脑中的瘦素-STAT3途径并引起
肥胖。使用CRISPR技术,已经生成了敲击鼠标线以模仿SRC-1遗传
与人肥胖相关的突变。这些小鼠的代谢表型将被表征,瘦素 -
STAT3动作和STAT3转录活动将进行评估。 AIM 3将确定下丘脑是否
SRC-2涂层FOXO1转录活性,以促进能量储备。缺乏或过表达的小鼠
已经产生了成熟的POMC神经元中的SRC-2,并且没有FOXO1过表达。代谢
在所有这些模型中都将表征表型,并且还将评估FOXO1转录活性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YONG XU其他文献
Synthesis of molybdenum disulfide from waste Mo materials
废钼原料合成二硫化钼
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
YONG -KUI CAI;YONG XU;XIAO -QIANG WANG;KUN -HONG HU - 通讯作者:
KUN -HONG HU
YONG XU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YONG XU', 18)}}的其他基金
Brain Estrogen Regulates Energy and Glucose Balance
大脑雌激素调节能量和血糖平衡
- 批准号:
10032667 - 财政年份:2020
- 资助金额:
$ 31.7万 - 项目类别:
Brain Estrogen Regulates Energy and Glucose Balance
大脑雌激素调节能量和血糖平衡
- 批准号:
10443842 - 财政年份:2020
- 资助金额:
$ 31.7万 - 项目类别:
Brain Estrogen Regulates Energy and Glucose Balance
大脑雌激素调节能量和血糖平衡
- 批准号:
10654694 - 财政年份:2020
- 资助金额:
$ 31.7万 - 项目类别:
Brain Estrogen Regulates Energy and Glucose Balance
大脑雌激素调节能量和血糖平衡
- 批准号:
10256073 - 财政年份:2020
- 资助金额:
$ 31.7万 - 项目类别:
Neurobiology for the sex differences in energy balance
能量平衡性别差异的神经生物学
- 批准号:
9901528 - 财政年份:2018
- 资助金额:
$ 31.7万 - 项目类别:
Project 1: Brain steroid receptor coactivators and energy homeostasis
项目1:脑类固醇受体共激活剂和能量稳态
- 批准号:
10421282 - 财政年份:2018
- 资助金额:
$ 31.7万 - 项目类别:
Neurobiology for the sex differences in energy balance
能量平衡性别差异的神经生物学
- 批准号:
10374807 - 财政年份:2018
- 资助金额:
$ 31.7万 - 项目类别:
Targeting hypothalamic steroid receptor co-activator-1 to treat obesity
靶向下丘脑类固醇受体辅激活剂-1 治疗肥胖
- 批准号:
8921991 - 财政年份:2014
- 资助金额:
$ 31.7万 - 项目类别:
相似国自然基金
脂肪组织新型内分泌因子的鉴定及功能研究
- 批准号:82330023
- 批准年份:2023
- 资助金额:220 万元
- 项目类别:重点项目
脂肪干细胞外泌体miRNA-299a-3p调控巨噬细胞Thbs1缓解脂肪组织衰老的机制研究
- 批准号:82301753
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
血管周围脂肪组织TRPV1通道通过脂联素调控肥胖相关高血压的机制研究
- 批准号:82300500
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
糖尿病脂肪组织中SIRT3表达降低进而上调外泌体miR-146b-5p促进肾小管脂毒性的机制研究
- 批准号:82370731
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
CXCL1/CXCR2信号轴上调Bcl-2促进筋膜定植巨噬细胞迁移在皮下脂肪组织原位再生中的机制研究
- 批准号:82360615
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
Nonalcoholic Fatty Liver Disease (NAFLD) in Polycystic Ovary Syndrome: The Role of Androgens on Liver Injury and NAFLD Progression
多囊卵巢综合征中的非酒精性脂肪肝 (NAFLD):雄激素在肝损伤和 NAFLD 进展中的作用
- 批准号:
10735807 - 财政年份:2023
- 资助金额:
$ 31.7万 - 项目类别:
Mucosal Associated Invariant T cells in the Obese-asthma endotype
肥胖哮喘内型中的粘膜相关不变 T 细胞
- 批准号:
10607523 - 财政年份:2023
- 资助金额:
$ 31.7万 - 项目类别:
Modulating Cellular Bioenergetics to Improve Skeletal Health
调节细胞生物能量以改善骨骼健康
- 批准号:
10661806 - 财政年份:2022
- 资助金额:
$ 31.7万 - 项目类别:
Caloric restriction-driven immunometabolic checkpoints of inflammation
热量限制驱动的炎症免疫代谢检查点
- 批准号:
10457565 - 财政年份:2022
- 资助金额:
$ 31.7万 - 项目类别:
Use of Novel Multi-modality Imaging to Evaluate the Relationship Between Sleep Duration, Vascular Inflammation, and Visceral Adiposity
使用新型多模态成像评估睡眠持续时间、血管炎症和内脏肥胖之间的关系
- 批准号:
10687854 - 财政年份:2022
- 资助金额:
$ 31.7万 - 项目类别: